异丁基三苯基溴化膦 | 22884-29-3

• 物质功能分类: 有机原料 - 有机膦化合物
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 异丁基三苯基溴化膦
• 中文别名: 碘化异丙基三苯鏻
• 英文名称: isobutyltriphenylphosphonium bromide
• 英文别名: 2-methylpropyl(triphenyl)phosphanium;bromide
• CAS: 22884-29-3
• 化学式: Br*C₂₂H₂₄P
• 分子量: 399.31
• InChiKey: VIKPDPHNYHUZQW-UHFFFAOYSA-M

物化性质

• 熔点：
  200-202 °C(lit.)
• 稳定性/保质期：
  如果按照规定使用和储存，则不会分解，请避免接触氧化物。

计算性质

• 辛醇/水分配系数(LogP)：
  1.64
• 重原子数：
  24
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.18
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 危险品标志：
  Xi
• 安全说明：
  S26,S37/39
• 危险类别码：
  R36/37/38
• WGK Germany：
  3
• 海关编码：
  2931900090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335
• 储存条件：
  保持贮藏器密封，放入一个紧密的容器中，并储存在阴凉、干燥的地方。

SDS

Name:	Isobutyltriphenylphosphonium bromide 99% Material Safety Data Sheet
Synonym:	Triphenylisobutylphosphonium bromide
CAS:	22884-29-3

Section 1 - Chemical Product MSDS Name:Isobutyltriphenylphosphonium bromide 99% Material Safety Data Sheet
Synonym:Triphenylisobutylphosphonium bromide

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
22884-29-3	Isobutyltriphenylphosphonium bromide	99	245-291-7

Hazard Symbols: XN
Risk Phrases: 22 36/37/38

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Harmful if swallowed. Irritating to eyes, respiratory system and skin.Light sensitive.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation.
Ingestion:
Harmful if swallowed. May cause irritation of the digestive tract.
Inhalation:
Causes respiratory tract irritation.
Chronic:
No information found.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. Dusts at sufficient concentrations can form explosive mixtures with air. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Runoff from fire control or dilution water may cause pollution.
Extinguishing Media:
In case of fire, use water, dry chemical, chemical foam, or alcohol-resistant foam. Use agent most appropriate to extinguish fire.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.

---

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation. Store protected from light.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances. Store protected from light.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use process enclosure, local exhaust ventilation, or other engineering controls to control airborne levels.
Exposure Limits CAS# 22884-29-3: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Crystalline powder
Color: white to light yellow
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 200-203 deg C
Autoignition Temperature: Not available.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: 265 deg C
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C22H24PBr
Molecular Weight: 399.29

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Light, dust generation, excess heat.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, oxides of phosphorus, irritating and toxic fumes and gases, carbon dioxide, hydrogen bromide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 22884-29-3 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
Isobutyltriphenylphosphonium bromide - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
IMO
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
RID/ADR
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing group:

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 22 Harmful if swallowed.
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
WGK (Water Danger/Protection)
CAS# 22884-29-3: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 22884-29-3 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 22884-29-3 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

合成制备方法

目前暂无相关描述。

用途

当前也未提供具体用途信息。

反应信息

• 作为反应物：
  描述：

  异丁基三苯基溴化膦 在 sodium hexamethyldisilazane 作用下， 以 乙醚 为溶剂， 以75%的产率得到Isobutylidene-triphenyl-λ⁵-phosphane
  参考文献：
  名称：

  通过分子磷炔前体的模块化合成进行合成和光谱研究

  摘要：

  据报道，一系列二苯并 7-磷酸降冰片二烯化合物 Ph3PC(R)PA（1-R；A = C14H10，蒽；R = Me、Et、iPr、sBu）能够进行热裂解以生成烷基取代的磷炔（RC≡P）与三苯基膦和蒽相伴。通过用适当的叶立德 Ph3P=CHR（2 当量）处理 ClPA 可以轻松制备这些分子前体。对于甲基、乙基和异丙基取代基，通过定量 31 P NMR 光谱测量溶液中的磷炔转化率为 56-73%。在化合物 1-Me 的情况下，通过 Eyring 分析研究其自发单分子断裂的动力学特征。通过溶液核磁共振光谱和气相旋转微波光谱直接检测得到的 1-磷酸丙炔。后一种技术允许首次测量磷 31 核自旋旋转耦合张量。核自旋-旋转耦合提供了旋转和 NMR 光谱之间的联系，并与化学位移各向异性相关。

  DOI：

  10.1021/jacs.8b09845
• 作为产物：
  描述：

  三苯基瞵硫 在 草酰氯 作用下， 以 甲苯 、 乙腈 为溶剂， 反应 72.67h， 生成 异丁基三苯基溴化膦
  参考文献：
  名称：

  A convenient and mild chromatography-free method for the purification of the products of Wittig and Appel reactions

  摘要：

  描述了一种温和的方法，可以方便地从Wittig和Appel反应的粗产物中去除磷烷氧化物。使用草酰氯进行后处理，生成不溶的氯磷铵盐（CPS），从而为多种反应提供无磷产品。CPS产物可以进一步转化为磷烷。

  DOI：

  10.1039/c2ob07074j
• 作为试剂：
  描述：

  2,2-二甲基-3-羟基丙醛 、 alkaline earth salt of/the/ methylsulfuric acid 在 咪唑 、 叔丁基过氧化氢 、 二异丁基氢化铝 、 异丁基三苯基溴化膦 、 D-(-)-酒石酸二异丙酯 作用下， 以 二氯甲烷 、 N,N-二甲基甲酰胺 、 苯 为溶剂， 反应 2.0h， 生成 {(2R,3R)-3-[2-(tert-Butyl-dimethyl-silanyloxy)-1,1-dimethyl-ethyl]-oxiranyl}-methanol
  参考文献：
  名称：

  Asymmetric synthesis of (R)-3,3-dimethyl-2-hydroxy-γ-butyrolactone en route to the formal synthesis of calcium D-pantothenate

  摘要：

  DOI：

  10.1016/s0040-4039(00)77292-3

文献信息

• [EN] PYRIDIN-3-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION<br/>[FR] DÉRIVÉS D'ACIDE PYRIDIN-3-YLE ACÉTIQUE UTILISÉS EN TANT QU'INHIBITEURS DE LA RÉPLICATION DU VIRUS DE L'IMMUNODÉFICIENCE HUMAINE
  申请人：VIIV HEALTHCARE UK NO 5 LTD

  公开号：WO2018127800A1

  公开（公告）日：2018-07-12

  Disclosed are compounds of Formula I, including pharmaceutically acceptable salts, pharmaceutical compositions comprising the compounds, methods for making the compounds and their use in inhibiting HIV integrase and treating those infected with HIV or AIDS. (I)

  公开了公式I的化合物，包括药用可接受的盐、包含这些化合物的药物组合物、制备这些化合物的方法，以及它们在抑制HIV整合酶和治疗HIV或艾滋病感染者中的用途。
• [EN] (3-HYDROXY-4-AMINO-BUTAN-2-YL) -3- (2-THIAZOL-2-YL-PYRROLIDINE-1-CARBONYL) BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS BETA-SECRETASE INHIBITORS FOR TREATING<br/>[FR] DÉRIVÉS DE (3-HYDROXY-4-AMINO-BUTAN-2-YL) -3- (2-THIAZOL-2-YL-PYRROLIDINE-1-CARBONYL) BENZAMIDE ET COMPOSÉS ASSOCIÉS UTILISÉS EN TANT QU'INHIBITEURS DE LA BÊTA-SÉCRÉTASE POUR LE TRAITEMENT
  申请人：COMENTIS INC

  公开号：WO2009042694A1

  公开（公告）日：2009-04-02

  The present invention provides novel beta-secretase inhibitors and methods for their use, including methods of treating of Alzheimer's disease. (Formula)

  本发明提供了新颖的β-分泌酶抑制剂及其使用方法，包括用于治疗阿尔茨海默病的方法。
• An Acid-Stable <i>tert</i>-Butyldiarylsilyl (TBDAS) Linker for Solid-Phase Organic Synthesis
  作者：Christine M. DiBlasi、Daniel E. Macks、Derek S. Tan

  DOI：10.1021/ol050370y

  日期：2005.4.1

  robust tert-butyldiarylsilyl (TBDAS) linker has been developed for solid-phase organic synthesis. This linker is stable to both protic and Lewis acidic reaction conditions, overcoming a significant limitation of previously reported silyl linkers. Solid-phase acetal deprotection, olefination, asymmetric allylation, and silyl protecting group deblocking reactions have been demonstrated with TBDAS-linked substrates

  [反应：见正文]已开发出一种新的，坚固的叔丁基二芳基甲硅烷基（TBDAS）接头，用于固相有机合成。该接头对质子和路易斯酸性反应条件均稳定，克服了先前报道的甲硅烷基接头的显着限制。用TBDAS连接的底物已经证明了固相缩醛脱保护，烯化，不对称烯丙基化和甲硅烷基保护基团解封反应。
• Enantioselective Nickel-Catalyzed Hydrocyanation of Vinylarenes Using Chiral Phosphine-Phosphite Ligands and TMS-CN as a Source of HCN
  作者：Anna Falk、Anna-Lena Göderz、Hans-Günther Schmalz

  DOI：10.1002/anie.201208082

  日期：2013.1.28

  Anti‐headache chemistry: In the presence of a tailored modular P,P ligand the nickel‐catalyzed addition of HCN, generated in situ from TMS‐CN, to styrene derivatives proceeds with an unprecedented level of stereocontrol (up to 97 % ee) to give 2‐aryl‐acetonitriles, for example, the depicted precursor of Ibuprofen.

  抗头痛药的化学性质：在存在定制的模块化P，P配体的情况下，由TMS-CN原位生成的镍催化的HCN加到苯乙烯衍生物中，其立体控制水平达到前所未有的水平（ee高达97％  ）给出2-芳基乙腈，例如所示的布洛芬前体。
• Enantio‐ and Regioselective NiH‐Catalyzed Reductive Hydroarylation of Vinylarenes with Aryl Iodides
  作者：Yuli He、Chuang Liu、Lei Yu、Shaolin Zhu

  DOI：10.1002/anie.202010386

  日期：2020.11.23

  A highly enantio‐ and regioselective hydroarylation process of vinylarenes with aryl halides has been developed using a NiH catalyst and a new chiral bis imidazoline ligand. A broad range of structurally diverse, enantioenriched 1,1‐diarylalkanes, a structure found in a number of biologically active molecules, have been obtained with excellent yields and enantioselectivities under extremely mild conditions

  使用NiH催化剂和新型手性双咪唑啉配体开发了乙烯基芳烃与芳基卤化物的高度对映和区域选择性加氢芳基化方法。在极其温和的条件下，以优异的收率和对映选择性获得了多种结构多样的，对映体富集的1,1-二芳基烷烃，该结构存在于许多生物活性分子中。